High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender

被引：0
|
作者：
Zhou, Zheng [1 ]
Rademaker, Alfred W. [2 ]
Gordon, Leo I. [2 ]
LaCasce, Ann S. [3 ]
Crosby-Thompson, Allison [3 ]
Vanderplas, Ann [4 ]
Abel, Gregory A. [3 ]
Rodriguez, Maria A. [5 ]
Nademanee, Auayporn [6 ]
Kaminski, Mark [7 ]
Czuczman, Myron S. [8 ]
Millenson, Michael M. [9 ]
Niland, Joyce [4 ]
Zelenetz, Andrew D. [10 ]
Friedberg, Jonathan W. [11 ]
Winter, Jane N. [2 ]
机构：
[1] Northwestern Univ, NW Mem Hosp, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[5] UT MD Anderson Canc Ctr, Houston, TX USA
[6] City Hope Natl Med Ctr, Duarte, CA USA
[7] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[8] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[9] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 413 - 417
  • [42] Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
    Terada, Yoshiki
    Nakamae, Hirohisa
    Aimoto, Ran
    Kanashima, Hiroshi
    Sakamoto, Erina
    Aimoto, Mizuki
    Inoue, Eri
    Koh, Hideo
    Nakane, Takahiko
    Takeoka, Yasunobu
    Ohsawa, Masahiko
    Koh, Ki-Ryang
    Yamane, Takahisa
    Nakao, Yoshitaka
    Ohta, Kensuke
    Mugitani, Atsuko
    Teshima, Hirofumi
    Hino, Masayuki
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [43] Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): An update.
    Habermann, TM
    Weller, E
    Morrison, VA
    Cassileth, PA
    Cohn, J
    Dakhil, S
    Gascoyne, RD
    Woda, B
    Fisher, R
    Peterson, BA
    Horning, SJ
    BLOOD, 2004, 104 (11) : 40A - 40A
  • [44] Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
    Yoshiki Terada
    Hirohisa Nakamae
    Ran Aimoto
    Hiroshi Kanashima
    Erina Sakamoto
    Mizuki Aimoto
    Eri Inoue
    Hideo Koh
    Takahiko Nakane
    Yasunobu Takeoka
    Masahiko Ohsawa
    Ki-Ryang Koh
    Takahisa Yamane
    Yoshitaka Nakao
    Kensuke Ohta
    Atsuko Mugitani
    Hirofumi Teshima
    Masayuki Hino
    Journal of Experimental & Clinical Cancer Research, 28
  • [45] SERUM B2-MICROGLOBULIN LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC SIGNIFICANCE UNDER TREATMENT WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T. P.
    Anastasopoulou, A.
    Constantinou, N.
    Angelopoulou, M. K.
    Stavroulaki, E.
    Kalpadakis, C.
    Sachanas, S.
    Pappis, V.
    Tsirkinidis, P.
    Moschoyiannis, M.
    Tsopra, O.
    Tzenou, T.
    Gassiamis, A.
    Yiakoumis, X.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Dimou, M.
    Georgiou, G.
    Plata, E.
    Viniou, N. A.
    Variamis, E.
    Konstantopoulos, K.
    Panayiotidis, P.
    Papadaki, H.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 393 - 394
  • [46] The impact of body weight and body mass index on outcomes of diffuse large B-cell lymphoma treated with axicabtagene ciloleucel.
    Wudhikarn, Kitsada
    Bansal, Radhika
    Khurana, Arushi
    Hathcock, Matthew
    Bennani, N. Nora
    Paludo, Jonas
    Villasboas, Jose Caetano
    Wang, Yucai
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] A pilot study of epratuzumab and rituximab in combination with CHOP chemotherapy (ER-CHOP) in previously untreated patients with diffuse large B-cell lymphoma (DLBCL).
    Micallef, INM
    Kahl, BS
    Gayko, U
    Cesano, A
    Ansell, SM
    Colgan, JP
    Geyer, S
    Maurer, MJ
    Inwards, DJ
    White, WL
    Horning, SJ
    Habermann, TM
    BLOOD, 2003, 102 (11) : 643A - 644A
  • [48] Magrolimab in Combination with Rituximab plus Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Maakaron, Joseph
    Asch, Adam S.
    Popplewell, Leslie L.
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colin
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    O'Hear, Carol
    Ren, Xuehan
    Villa, Bertha
    Lal, Indu
    Smith, Sonali M.
    Advani, Ranjana H.
    BLOOD, 2022, 140 : 3728 - 3730
  • [49] Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma
    Ho-Jin Shin
    Joo Seop Chung
    Moo-Kon Song
    Seon-Kyeong Kim
    Sangmin Choe
    Goon-Jae Cho
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1165 - 1172
  • [50] Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma
    Shin, Ho-Jin
    Chung, Joo Seop
    Song, Moo-Kon
    Kim, Seon-Kyeong
    Choe, Sangmin
    Cho, Goon-Jae
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1165 - 1172
12345